|
Extension of Loan Agreement with RIPL
|
28 June 2023 at 9:00am
|
|
Company Update on Sale of Orthopaedic Asset
|
2 May 2023 at 7:40pm
|
|
AMT Submits 510(k) for Spinal Cage FDA Clearance
|
31 March 2023 at 8:45am
|
|
Appendix 4D and Half Year Financial Report
|
24 February 2023 at 12:50pm
|
|
Large Animal Study Completed Showing Positive Results
|
22 February 2023 at 9:45am
|
|
Company Update Correction
|
2 February 2023 at 4:30pm
|
|
Company Update
|
2 February 2023 at 3:05pm
|
|
Constitution
|
30 November 2022 at 10:45am
|
|
Results of Meeting
|
30 November 2022 at 10:40am
|
|
2022 AGM Notice of Meeting and Proxy
|
31 October 2022 at 9:45am
|
|
2022 AGM Letter to Shareholders and Proxy
|
31 October 2022 at 9:40am
|
|
Date of Annual General Meeting 2022
|
23 September 2022 at 9:35am
|
|
Appendix 4E and Audited Financial Statements
|
26 August 2022 at 6:45pm
|
|
Appendix 4G and Corporate Governance Statement
|
26 August 2022 at 6:35pm
|
|
Change in substantial holding
|
26 August 2022 at 4:45pm
|
|
Change of Director's Interest Notice - NH
|
26 August 2022 at 4:45pm
|
|
Company Update
|
11 August 2022 at 1:20pm
|
|
Biological Testing Sr-HT-Gahnite Further Safety Evidence
|
5 August 2022 at 8:45am
|
|
Notification of cessation of securities - AMT
|
11 July 2022 at 9:45am
|
|
Milestone Achieved Sr-HT-Gahnite Systemic Safety Evidence
|
14 March 2022 at 9:25am
|
|
Appendix 4D and Half Year Financial Report
|
24 February 2022 at 6:20pm
|
|
Final Director's Interest Notice
|
10 February 2022 at 3:35pm
|
|
Resignation of Company Director
|
8 February 2022 at 9:20am
|
|
Change of Company Secretary
|
4 February 2022 at 4:25pm
|
|
Large Animal Study Shows Positive Results
|
31 January 2022 at 2:20pm
|
|
COVID 19 and FY2022 Results Guidance
|
19 January 2022 at 10:30am
|
|
Results of Meeting
|
15 December 2021 at 12:35pm
|
|
AGM Letter to Shareholders
|
11 November 2021 at 5:45pm
|
|
Notice of Annual General Meeting/Proxy Form
|
11 November 2021 at 5:30pm
|
|
Appendix 4G & Corporate Governance Statement
|
29 October 2021 at 5:35pm
|
|
Annual Report to shareholders
|
29 October 2021 at 5:30pm
|
|
Appendix 4E & Full Year Statutory Accounts
|
26 August 2021 at 6:10pm
|
|
Improving Coating Techniques for Orthopaedic Implants
|
9 August 2021 at 9:35am
|
|
Change of Share Registry
|
26 July 2021 at 5:55pm
|
|
Loan to Progress Bone Substitute Project
|
28 April 2021 at 12:25pm
|
|
Allegra Announces new Head of Technology and Innovation
|
19 April 2021 at 9:30am
|
|
Successful pilot animal study
|
6 April 2021 at 9:35am
|
|
Half Yearly Report
|
24 February 2021 at 2:40pm
|
|
Further Positive Test Results - Spinal Cage Device
|
21 December 2020 at 10:05am
|
|
Spinal Cage Device Positive Test Results
|
4 December 2020 at 12:05pm
|
|
Change of Director's Interest Notice
|
10 November 2020 at 7:55pm
|
|
Appendix 3G
|
10 November 2020 at 7:35pm
|
|
Change of Director's Interest Notice
|
4 November 2020 at 9:15am
|
|
Results of Meeting
|
28 October 2020 at 11:30am
|
|
Section 708A Notice
|
22 October 2020 at 5:50pm
|
|
Appendix 2A
|
22 October 2020 at 5:50pm
|
